Anchalee Avihingsanon, MD, PhD presents results showing 95.4% HIV RNA suppression and 86.6% HBV DNA suppression after 48 weeks of B/F/TAF in HIV-HBV co-infected patients.
Anchalee Avihingsanon, MD, PhD
Advertisement
Principal Investigator of the ALLIANCE trial and affiliated with HIV-NAT at the Thai Red Cross AIDS Research Centre in Bangkok, Thailand.
Articles by Anchalee Avihingsanon, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Nearly 1 in 5 Urinary Tract Infections in Southern California Linked to Contaminated Meat
2
Top Infectious Disease News Stories Week of October 18-October 24
3
Moderna Discontinues Development of Vaccine for Congenital CMV After Not Meeting Primary Efficacy Endpoint
4
High Continued Adherence of Lenacapavir in Individuals Who Use Substances and Alcohol
5
